July 7, 2026 D-Wave Is One of Only Two Companies Named to the Leaders Category in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment
July 7, 2026 Molecular Targeting Technologies Presents First Clinical Validation of the Evans Blue Platform, Demonstrating Up to 15-Day Tumor Retention Using Approximately 12.5% of the Radioactivity Required for Conventional PRRT
July 7, 2026 Amerigroup Georgia Recognizes Dalton-Based Peds Care Among Nation’s Top Primary Care Practices
